BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, July 8, 2025
See today's BioWorld
Home
» FDA sets out 2022 menu of fees
To read the full story,
subscribe
or
sign in
.
FDA sets out 2022 menu of fees
Aug. 16, 2021
By
Mari Serebrov
New PDUFA, BsUFA and GDUFA user fees go into effect Oct. 1 in the U.S.
BioWorld
Drugs
Regulatory
U.S.
FDA